Insider trades

Richard Christopher, CEO of Lexaria Bioscience LEXX, has filed 3 purchases and 0 sales on the open market. The latest trade was on 25/07/29.

Richard Christopher

CEO
First filing
24/12/03
Trades
4 trades
Buys / sales
3 / 0
12-month net buying
No record
Last trade
25/07/29

Trading activity

Transactions

Trade type
Open-market buy25/07/2925/07/3015,000 sh$0.91$13,650+30.0%
LEXX
Open-market buy24/12/02–24/12/0324/12/0350,000 sh2 trades$2.36avg.$118,249.56No record